These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35660114)

  • 1. Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform.
    Pinto M; Silva V; Barreiro S; Silva R; Remião F; Borges F; Fernandes C
    Ageing Res Rev; 2022 Aug; 79():101658. PubMed ID: 35660114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polylactic-co-glycolic acid-based nanoparticles modified with peptides and other linkers cross the blood-brain barrier for targeted drug delivery.
    Na Y; Zhang N; Zhong X; Gu J; Yan C; Yin S; Lei X; Zhao J; Geng F
    Nanomedicine (Lond); 2023 Jan; 18(2):125-143. PubMed ID: 36916394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform.
    Bazi Alahri M; Jibril Ibrahim A; Barani M; Arkaban H; Shadman SM; Salarpour S; Zarrintaj P; Jaberi J; Turki Jalil A
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrier.
    Chaturvedi M; Molino Y; Sreedhar B; Khrestchatisky M; Kaczmarek L
    Int J Nanomedicine; 2014; 9():575-88. PubMed ID: 24531257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit
    Naeem M; Bae J; Oshi MA; Kim MS; Moon HR; Lee BL; Im E; Jung Y; Yoo JW
    Int J Nanomedicine; 2018; 13():1225-1240. PubMed ID: 29535519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
    Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
    Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review on Designing Poly (Lactic-co-glycolic Acid) Nanoparticles as Drug Delivery Systems.
    Naskar S; Das SK; Sharma S; Kuotsu K
    Pharm Nanotechnol; 2021; 9(1):36-50. PubMed ID: 33319695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular Targeting of Poly Lactic-Co-Glycolic Acid Nanoparticles by Surface Functionalization with Peptides.
    de Oliveira TD; Travassos LR; Arruda DC; Tada DB
    J Biomed Nanotechnol; 2021 Jul; 17(7):1320-1329. PubMed ID: 34446135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLGA-based nanoparticles as cancer drug delivery systems.
    Sadat Tabatabaei Mirakabad F; Nejati-Koshki K; Akbarzadeh A; Yamchi MR; Milani M; Zarghami N; Zeighamian V; Rahimzadeh A; Alimohammadi S; Hanifehpour Y; Joo SW
    Asian Pac J Cancer Prev; 2014; 15(2):517-35. PubMed ID: 24568455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine I: In vitro and in vivo evaluation of paclitaxel loaded poly-(ε-caprolactone), poly (DL-lactide-co-glycolide) and poly (DL-lactic acid) matrix nanoparticles in wistar rats.
    VasanthaKumar S; Ahamed HN; Saha RN
    Eur J Drug Metab Pharmacokinet; 2015 Jun; 40(2):137-61. PubMed ID: 24671895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.
    Tosi G; Fano RA; Bondioli L; Badiali L; Benassi R; Rivasi F; Ruozi B; Forni F; Vandelli MA
    Nanomedicine (Lond); 2011 Apr; 6(3):423-36. PubMed ID: 21542682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
    Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
    Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(lactic-co-glycolic) Acid (PLGA) Nanoparticles and Transdermal Drug Delivery: An Overview.
    Kumar L; Kukreti G; Rana R; Chaurasia H; Sharma A; Sharma N; Komal
    Curr Pharm Des; 2023; 29(37):2940-2953. PubMed ID: 38173050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative receptor based brain delivery of tramadol-loaded poly(lactic-co-glycolic acid) nanoparticles.
    Lalani J; Raichandani Y; Mathur R; Lalan M; Chutani K; Mishra AK; Misra A
    J Biomed Nanotechnol; 2012 Dec; 8(6):918-27. PubMed ID: 23030000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evaluation of time-dependent antithrombotic effect of rivaroxaban-loaded poly(lactic-co-glycolic acid)/sodium lauryl sulfate or didodecyl dimethylammonium bromide nanoparticles in Wistar rats.
    de Souza Furtado P; Agnes Silva Camargo de Oliveira A; Santiago Rodrigues P; Rita Santiago de Paula Gonçalves A; Raphaella Autran Colaço A; Pinheiro da Costa S; Muniz da Paz M; Wetler Meireles Carreiros Assumpção P; Pereira Rangel L; Simon A; Almada do Carmo F; Mendes Cabral L; Cunha Sathler P
    Eur J Pharm Biopharm; 2023 Sep; 190():184-196. PubMed ID: 37517449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuning the Size of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles Fabricated by Nanoprecipitation.
    Huang W; Zhang C
    Biotechnol J; 2018 Jan; 13(1):. PubMed ID: 28941234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.
    Avgoustakis K
    Curr Drug Deliv; 2004 Oct; 1(4):321-33. PubMed ID: 16305394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.